“Our hope is that in places where HIV is running rampant, people could use this gel as a preventive measure to stop the initial infection,”
Nanoparticles carrying a toxin found in bee venom can destroy human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS.
“Our hope is that in places where HIV is running rampant, people could use this gel as a preventive measure to stop the initial infection,” says Joshua L. Hood, MD, PhD, a research instructor in medicine.
The study appears in the current issue of Antiviral Therapy.
Bee venom contains a potent toxin called melittin that can poke holes in the protective envelope that surrounds HIV, and other viruses. Large amounts of free melittin can cause a lot of damage. Indeed, in addition to anti-viral therapy, the paper’s senior author, Samuel A. Wickline, MD, the J. Russell Hornsby Professor of Biomedical Sciences, has shown melittin-loaded nanoparticles to be effective in killing tumor cells.
The new study shows that melittin loaded onto these nanoparticles does not harm normal cells. That’s because Hood added protective bumpers to the nanoparticle surface. When the nanoparticles come into contact with normal cells, which are much larger in size, the particles simply bounce off. HIV, on the other hand, is even smaller than the nanoparticle, so HIV fits between the bumpers and makes contact with the surface of the nanoparticle, where the bee toxin awaits.
According to Hood, an advantage of this approach is that the nanoparticle attacks an essential part of the virus’ structure. In contrast, most anti-HIV drugs inhibit the virus’s ability to replicate. But this anti-replication strategy does nothing to stop initial infection, and some strains of the virus have found ways around these drugs and reproduce anyway.
“We are attacking an inherent physical property of HIV,” Hood says. “Theoretically, there isn’t any way for the virus to adapt to that. The virus has to have a protective coat, a double-layered membrane that covers the virus.”
Beyond prevention in the form of a vaginal gel, Hood also sees potential for using nanoparticles with melittin as therapy for existing HIV infections, especially those that are drug-resistant. The nanoparticles could be injected intravenously and, in theory, would be able to clear HIV from the blood stream.
“The basic particle that we are using in these experiments was developed many years ago as an artificial blood product,” Hood says. “It didn’t work very well for delivering oxygen, but it circulates safely in the body and gives us a nice platform that we can adapt to fight different kinds of infections.”
Since melittin attacks double-layered membranes indiscriminately, this concept is not limited to HIV. Many viruses, including hepatitis B and C, rely on the same kind of protective envelope and would be vulnerable to melittin-loaded nanoparticles.
While this particular paper does not address contraception, Hood says the gel easily could be adapted to target sperm as well as HIV. But in some cases people may only want the HIV protection.
The Latest Bing News on:
- Antibiotic Resistance Causes More Deaths Than Malaria And HIV/Aids Combined. What Africa Is Doing To Fight This Silent Epidemicon February 29, 2024 at 7:14 pm
(MENAFN- The Conversation) Each year antimicrobial resistance – the ability of microbes to survive agents designed to kill them – claims more lives than malaria and HIV/Aids combined. Africa bears the ...
- Are We Any Closer To An HIV Vaccine?on February 28, 2024 at 8:31 am
Together with tuberculosis, HIV (the human immunodeficiency virus) is a leading infectious global health threat. In 2022, there were 1.3 million new infections and about 630,000 people died from ...
- SA pilot project now offering an HIV prevention injectionon February 27, 2024 at 9:30 am
A new HIV prevention injection is now available to a select number of people in South Africa (SA). A major selling point is that a single shot provides two months of protection. How much of this jab ...
- Patient cured of HIV and leukemia is ‘extremely grateful’ 5 years after stem cell transplanton February 26, 2024 at 10:17 pm
Five years after receiving a life-changing stem cell transplant, a 68-year-old man says he’s “extremely grateful” to be essentially cured of acute myelogenous leukemia and in HIV remission.
- What is HIV viral load?on February 26, 2024 at 4:00 pm
Viral load refers to the amount of HIV in a person’s blood. HIV treatments aim to reduce the viral load until the virus is no longer detectable, which means it is also untransmittable.
- How long can a person live with HIV?on February 26, 2024 at 4:00 pm
The life expectancy of a person living with HIV has improved dramatically over recent years. Thanks to advances in antiretroviral therapy (ART), many people living with HIV can now live long lives.
- HIV and AIDS Newson February 24, 2024 at 4:00 pm
The vaccinated monkeys remained free of AIDS for six years and ... Researchers Are Using RNA in a New Approach to Fight HIV Feb. 20, 2024 — A pharmacy associate professor has developed a novel ...
- Hydeia Broadbent, young activist for HIV/AIDS awareness, dies at 39on February 24, 2024 at 9:01 am
Hydeia Broadbent, who was born with HIV and spent nearly her entire life — ever since she was a young girl — as an advocate for HIV/AIDS awareness and prevention, died Feb. 20 at a neurological ...
- Rise in new HIV/Aids infections among women worries leaderson February 22, 2024 at 10:31 pm
Despite the HIV/Aids prevalence rate remaining at 17 percent in Fort Portal City, there is an alarming trend of new infections being registered in women than in men ...
- Hydeia Broadbent, HIV/AIDS activist who raised awareness on tv at young age, dies at 39on February 22, 2024 at 10:55 am
Hydeia Broadbent, HIV/AIDS activist since childhood who appeared on Oprah and 'Good Morning America', has died at age 39.
The Latest Google Headlines on:
[google_news title=”” keyword=”killing HIV” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Nanoparticle drug delivery
- SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Canceron February 29, 2024 at 2:09 am
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on Feb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug ...
- Investigating cell killers: An advanced system for size-dependent cytotoxicity analysis of silicaon February 28, 2024 at 3:59 pm
Scientists have attributed this behavior of metal nanoparticles in interaction with biomolecules ... "SiNPs have gained momentum in various fields such as drug delivery, biomedical imaging, catalysts ...
- Study reveals how innovative chemotherapy approach works against lung canceron February 26, 2024 at 11:42 am
Lung cancer is not the most frequent type of cancer but it is by far the most deadly Despite therapies such as surgery radiation therapy and chemotherapy o ...
- Global Magnetite Nanoparticles Market Is Expected To Reach US$ 191.4 Million By 2032: IMARC Groupon February 25, 2024 at 12:46 am
The latest report by IMARC Group, titled“ Magnetite Nanoparticles Market Report by Type (Iron Based, Cobalt Based), Phy ...
- Nanotechnology for targeted drug deliveryon February 24, 2024 at 2:18 pm
What is nanotherapy? Nanoparticles can be used in targeted drug delivery to improve the bioavailability, biodistribution, and accumulation of therapeutics, preferentially in the targeted diseased area ...
- Inhalable nanoparticles could help treat chronic lung diseaseon February 6, 2024 at 4:00 pm
These findings suggest the nanoparticles could improve drug delivery in people with COPD or other lung conditions like cystic fibrosis where thick mucus makes it difficult to treat infections ...
- Biosensing Instrument's SPRm200 Systemon February 1, 2024 at 4:00 pm
bacteria and nanoparticles Nanomotion detection study of bacteria or virus metabolic activity or binding activities of nanoparticles for drug delivery designs.
- Tumor targeting using nanoparticle-based drug and gene deliveryon February 1, 2024 at 2:34 am
PEGs are non-toxic and find widespread use in bioconjugation, surface functionalization, biomedical research, drug delivery, tissue engineering, and the food and cosmetics sectors. The process of ...
- Nanoparticle transport across the blood brain barrier increases with Alzheimer's and age, study findson January 4, 2024 at 9:45 am
They are also planning to measure how long their nanoparticles can be retained in the brain, which could help provide longer and more consistent drug delivery to patients treated with ...
The Latest Google Headlines on:
Nanoparticle drug delivery
[google_news title=”” keyword=”nanoparticle drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]